ETF1 and tick-borne infectious disease: In addition to providing a potential treatment of the tick-born disease, the macrocyclic peptidyl Etf-1 inhibitors have served as useful chemical probes to gain significant insight into the molecular mechanism of E. chaffeensis infection.